Optimized clinical pathway protocol
Optimized clinical pathway protocol has been studied in 1 paper since 2025: 1 trial in people. The newest paper, Jul 26, 2025: “Effect of an Optimized Clinical Pathway Protocol Including Fascia Iliaca Compartment Block on Delirium and Postoperative Complications in Elderly Hip Fracture Patients”.
1 paper studies it3 findingsUpdated
“The OCPP intervention significantly reduced the incidence of postoperative delirium from 44% to 29% (a 33% relative reduction; p = 0.017)”
None of its findings points the other way.
- 1 lab in 1 country
- Funder: anesthesia department
- Human trial1
Studies in people
1 study gave optimized clinical pathway protocol to people and measured what changed.
down: Decreases postoperative deliriumOR 0.52 (95% CI 0.31 to 0.98)
no change: Has no effect on 1-year mortality
Trial≥65 years oldMarch 2020 to June 2022
Journal of clinical medicine, Jul 26, 2025
What did studies of Optimized clinical pathway protocol find?
2Studies of Optimized clinical pathway protocol measured 2 outcomes; the most studied are postoperative delirium (1 study) and 1-year mortality (1).
Postoperative delirium
downin humans1OR 0.52
1 study
Postoperative delirium
downin humans1OR 0.52
Optimized clinical pathway protocol decreases postoperative delirium in humans (OR 0.52 (95% CI 0.31 to 0.98)).
“Specifically, the incidence of postoperative delirium was lower in the pathway group (29.3%; 95% CI, 21.0% to 38.0%) than in the control group (43.8%; 95% CI, 35.0% to 52.0%; p = 0.015), with an Odds Ratio of 0.52 (95% CI 0.31 to 0.98).”
Human trial
Journal of clinical medicine
Optimized clinical pathway protocol decreases postoperative delirium in humans (44% to 29%, 33% relative reduction, p = 0.017).
“The OCPP intervention significantly reduced the incidence of postoperative delirium from 44% to 29% (a 33% relative reduction; p = 0.017)”
Human trialgeriatric hip fracture patients undergoing surgery
Journal of clinical medicine
1-year mortality
no changein humans1
1 study
1-year mortality
no changein humans1
Optimized clinical pathway protocol has no effect on 1-year mortality in humans.
“No differences were observed on hospital stay and 1-year mortality.”
Human trial
Journal of clinical medicine